Project Grant R21AI194543
Award Date
7/23/25
Completion Date
6/30/27
Dollars Obligated
$414K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,504,456 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Chicago. The 5-year grant, awarded on August 15, 2024, will support research using artificial intelligence to bridge human and murine studies of lupus nephritis progression. Specifically, the project aims to investigate tubulointerstitial hypoxia, metabolic dysfunction, capillary rarefaction, immune...
This $793,093 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to define the regulatory landscape of systemic lupus erythematosus (SLE) and its cardiovascular disease (CVD) comorbidity. The grantee, Oklahoma Medical Research Foundation, will conduct systematic, high-throughput studies in macrophages derived from induced pluripotent stem cells to identify genetic variants that disrupt regulatory...
The University of Massachusetts Medical School was awarded a $494,929 Project Grant from the National Institute of Allergy and Infectious Diseases to study the role of Toll-like receptors, type II interferon and type III interferon in a murine model of autoinflammation. The grant will support research exploring the effector mechanisms responsible for inducing and regulating cutaneous lupus using genetically modified mice with discriminating mutations. Specifically, the researchers will use...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $555,774.00 to the University of Alabama at Birmingham (UAB) over a 5-year period starting November 19, 2024. The award supports research to investigate the role of the aryl hydrocarbon receptor (AhR) pathway in regulating the development of T-bet+ B cells, which are implicated in the pathogenesis of systemic lupus...
The federal Project Grant award R21AI183127, totaling $423,500.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The primary goal of this 2-year award to Loyola University of Chicago is to develop novel antibodies that specifically target autoreactive B cells as a potential therapeutic approach for treating systemic lupus erythematosus (SLE), particularly in African American patients...
This federal Project Grant award, valued at $715,957 and awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, supports research to elucidate the molecular mechanisms by which interferon cytokines promote the differentiation and expansion of T peripheral helper (Tph) cells in systemic lupus erythematosus (SLE) patients. The award, with a project period from March 2025 to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Program (CFDA 93.855), provides $256,808 to the University of Washington to investigate the role of dysregulated mRNA splicing in systemic lupus erythematosus (SLE). The goal is to better define the molecular mechanisms that cause and perpetuate SLE by examining altered protein structures and neoepitopes in lupus neutrophils. The research...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $689,051 to Health Research, Inc. to develop therapeutic potential of the mycobacteriophage lysin, LysB, for the treatment of life-threatening Mycobacterium abscessus (MAB) infections. The key objectives are to generate a cocktail of complementary LysB enzymes, decipher the mechanism of MAB lysis by LysB, and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $709,019 to the Benaroya Research Institute at Virginia Mason in Seattle, WA to conduct research on the role of the FOXP3 isoform in regulating autoantibody production and the development of systemic lupus erythematosus (SLE). The key objectives are to: 1) determine how the FOXP3 exon 2 isoform impacts germinal...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop a simplified and cost-effective mouse model of Mycobacterium abscessus lung disease. The $426,938 award to The Johns Hopkins University will fund research to verify the reproducibility of a new mouse model using additional M. abscessus isolates and evaluate the model's ability to replicate the efficacy...